Skip to search formSkip to main contentSkip to account menu

bevacizumab

Known as: Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF Monoclonal Antibody, Monoclonal Antibody Anti-VEGF 
A drug used to treat several types of cancer, including certain types of colorectal, lung, breast, and kidney cancers and glioblastoma. It is also… 
National Institutes of Health

Related topics

Related topics

28 relations
16 ML bevacizumab 25 MG/ML Injection [Avastin]4 ML bevacizumab 25 MG/ML InjectionAngiogenesis InhibitionCAPOX-Bevacizumab Regimen

Broader (1)

Angiogenesis Inhibitors

Narrower (1)

Avastin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
In Vitro and In Vivo Release of Vascular Endothelial Growth Factor from Gelatin Microparticles and Biodegradable Composite Scaffolds
PurposeThis work evaluated gelatin microparticles and biodegradable composite scaffolds for the controlled release of vascular… 
Review
2008
Review
2008
Subconjunctival Bevacizumab for Corneal Neovascularization in Herpetic Stromal Keratitis
Purpose: To report an 81-year-old woman with corneal neovascularization secondary to herpetic stromal keratitis treated with… 
Highly Cited
2005
Highly Cited
2005
Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced…
BACKGROUND Plasma and serum biomarkers of angiogenesis and activated endothelial cells were evaluated to assess biological… 
Highly Cited
2004
Highly Cited
2004
Nitric Oxide Production and Regulation of Endothelial Nitric-oxide Synthase Phosphorylation by Prolonged Treatment with Troglitazone
Recently, peroxisome proliferator-activated receptor γ (PPARγ) ligands have been reported to increase endothelial NO, but the… 
Highly Cited
2003
Highly Cited
2003
The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells
We recently identified an angiogenic mitogen, endocrine-gland-derived vascular endothelial growth factor (EG-VEGF), with… 
Highly Cited
2003
Highly Cited
2003
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Inhibition of the vascular endothelial growth factor VEGF-VEGF receptor (VEGF-R) kinase axes in the tumor angiogenic cascade is a… 
Highly Cited
2002
Highly Cited
2002
Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
Highly Cited
1999
Highly Cited
1999
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and…
The formation of new vessels (angiogenesis) is essential for primary tumour growth and metastasis and is induced by several… 
Highly Cited
1999
Highly Cited
1999
Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
Vascular endothelial growth factor (VEGF)‐A is known to play an important role in tumor angiogenesis. Three additional members of… 
Highly Cited
1999
Highly Cited
1999
A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
VEGF-A induces angiogenesis and regulates endothelial function via production and release of nitric oxide (NO), which is produced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)